Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification

Med Pediatr Oncol. 2003 Jul;41(1):80-2. doi: 10.1002/mpo.10287.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Fatal Outcome
  • Female
  • Humans
  • Infant
  • L-Lactate Dehydrogenase / blood*
  • N-Myc Proto-Oncogene Protein
  • Neuroblastoma / blood
  • Neuroblastoma / drug therapy
  • Neuroblastoma / genetics*
  • Neuroblastoma / pathology
  • Nuclear Proteins / genetics*
  • Oncogene Proteins / genetics*
  • Retroperitoneal Neoplasms / blood
  • Retroperitoneal Neoplasms / drug therapy
  • Retroperitoneal Neoplasms / genetics*
  • Retroperitoneal Neoplasms / pathology
  • Tumor Lysis Syndrome / etiology

Substances

  • MYCN protein, human
  • N-Myc Proto-Oncogene Protein
  • Nuclear Proteins
  • Oncogene Proteins
  • L-Lactate Dehydrogenase